The funds from Trinity Capital are expected to advance commercialisation efforts for Cala Health’s device for alleviating tremors in Parkinson’s and essential tremor patients.

BVI’s next-generation cataract and vitreoretinal procedure platform has been developed with features that are intended at improving patient outcomes.

Medtronic has completed the acquisition of CathWorks, a company specialising in advancing the diagnosis and treatment of CAD, for $585m.

Pulnovo Medical has completed an oversubscribed $100m strategic financing round, with Medtronic as the lead investor.

OEMs continue to prioritise high-growth segments of the medtech industry such as pulsed-field ablation (PFA), while conflict in the Middle East is impacting IPO activity.

ScreenPoint’s Transpara AI is integrated with Siemens Healthineers tools, including syngo.Breast Care and its MAMMOMAT range.

The Bruker Microbiology & Infection Diagnostics division has announced the European launch of its MyGenius PRO automated S2A molecular diagnostics system at the ESCMID Global 2026.

Validated biomarkers help physicians identify patients that will benefit most from certain treatments, but implementation challenges remain.

Waters BD Onclarity HPV assay is intended to remove barriers that prevent individuals from receiving routine cervical cancer screening.

Philips has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Verida spectral CT system.

Amplitude Vascular’s lead development product is an intravascular lithotripsy platform for calcified peripheral artery disease treatment.

CorTec's BCI aims to differentiate itself by offering brain-based communication alongside therapeutic neurostimulation.